Topics

Biogen scraps two late-stage trials for Alzheimer's treatment

13:11 EDT 13 Sep 2019 | Reuters

Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.

Original Article: Biogen scraps two late-stage trials for Alzheimer's treatment

NEXT ARTICLE

More From BioPortfolio on "Biogen scraps two late-stage trials for Alzheimer's treatment"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...